The appetite suppression stabilizes
Nevertheless, the team did emphasize that the short follow-up period in their study may be insufficient to fully capture the chronic trajectory of glaucoma development, particularly given the recent FDA approval of tirzepatide
65 However, a controlled, randomized, double-blind, multicenter study assessing the safety, tolerability, pharmacokinetics, and efficacy of nidufexor in patients with MASH was terminated without results posted (NCT02913105)
doi: 10.1242/dev.166074 114 RaeC
At Nulife Health & Wellness, we provide transparent pricing and work closely with you to choose the right peptide treatment plan that fits your goals and budget